Skip to main content
. 2017 Jun 13;8(57):96852–96864. doi: 10.18632/oncotarget.18451

Figure 5. Cancer biology of LLC-SD and LLC-ASD in C57BL/6 mice.

Figure 5

(A) the survival proportion of C57/B6 mice injected with 105 LLC-SD and 105 LLC-ASD cells respectively. (B) immunohistochemistry analysis of the tumor derived from LLC-SD and LLC-ASD in C57/B6 mice lung in situ.